Inflation Reduction Act: Access Barriers Undermine Affordability
Enacted in 2022, the Inflation Reduction Act (IRA) introduced significant reforms aimed at reducing the financial burden of prescription drug costs for Medicare Part D beneficiaries.
A new report from MAPRx, however, shows that as a larger share of liability has shifted from the federal government to plans and pharmaceutical manufacturers, plan behavior is seen changing... Read more



